A “unique” new medicine has been launched to ease constipation in babies as young as six months old.
The common condition affects between 5 and 30% of the child population with up to four in 10 children likely to develop constipation in their first year.
Docusol Paediatric Solution, manufactured by Typharm, is being offered as an over-the-counter medicine aimed at keeping constipated children out of doctor’s surgeries.
It also acts as a gentle stimulant to ease the condition.
Chandra Ondhia, managing director at Typharm, said: “All the hospitals around the country have a constipation clinic – there is an area where they send all the children and adults as well.”
He advised the product could be used for five days before patients would need to consult with a GP.
“It is specifically licensed for children as young as six months which is a real unique point of difference in terms of laxatives,” said Faye Carter, marketing manager at Typharm.
“OTC laxative sales have been flat in the UK over the last few years, with an estimated market value of £53.4m.
“We are confident with Docusol Paediatric Solution there is now an opportunity to invigorate the market with the introduction of a unique and differentiated product, driving both volume and growth.”
There are an estimated 270,000 cases of infant constipation in the UK each year.